Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-09-18

FDA Approved: PANTOPRAZOLE SODIUM DELAYED-RELEASE — Supplemental Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approved a supplemental application for Pantoprazole Sodium Delayed-Release from Lifestar Pharma LLC, approving a new generic pantoprazole product. The appr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pantoprazole sodium delayed-release (pantoprazole sodium)

Snippet

SUPPL AP for PANTOPRAZOLE SODIUM DELAYED-RELEASE (PANTOPRAZOLE SODIUM DELAYED-RELEASE)